Switzerland changes infringement test for combination product SPCs
In a landmark decision, the Swiss Federal Supreme Court confirmed the validity of Gilead’s Truvada SPC and ruled that future SPCs for combination products must meet CJEU case law requirements
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: